Targeting Interleukin (IL) 5 for Asthma and Hypereosinophilic Diseases

E-ISSN： 2212-2710|4|3|201-209

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.4, Iss.3, 2010-11, pp. : 201-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation, Allergy and Asthma, Complex Immune Origin Diseases: Mechanisms and Therapeutic Agents

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 7, Iss. 1, 2013-01 ,pp. : 62-95

Bentham Science Publishers

Access to resources Recommend Favorite

The Relevance of IgE in the Pathogenesis of Allergy: The Effect of an Anti-IgE Drug in Asthma and Other Diseases

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 151-164

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Damage Impact on Aging and Age-Related Diseases: Drug Targeting of Telomere Attrition and Dynamic Telomerase Activity Flirting with Imidazole-Containing Dipeptides

Recent Patents on Drug Delivery & Formulation, Vol. 8, Iss. 3, 2014-12 ,pp. : 163-192

Bentham Science Publishers

Access to resources Recommend Favorite

Obesity and Asthma

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 162-172

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents for the Treatment of Asthma

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 10, Iss. 1, 2016-04 ,pp. : 13-20

Bentham Science Publishers

Access to resources Recommend Favorite